Precision Vision is proud to introduce Precision Vision University (PVU).
PVU will be your source for videos from some of the leading experts in Visual Acuity, Low Vision, Contrast Sensitivity and more. There you will find video tutorials and product demonstrations for many of our most popular products as well as topics of discussion and educational content that are not product related.
PVU can be found on our newly established YouTube Channel or soon on our website.
Our first production (below) features noted Ophthalmologists Dr. Donald Fletcher and Dr. Gianfrancesco Villani as they discuss the many merits of utilizing the SK Read Test. Not seeing a topic that you would like us to address? E-mail us your topic to [email protected].
Dr. August Colenbrander, MD Affiliate Senior Scientist at the Smith-Kettlewell Eye Research Institute was recently honored at the 2013 Envision Conference in Minneapolis, MN.
Dr. Colenbrander was awarded a Lifetime Achievement Award for his contributions to the field of Low Vision Rehabilitation.
Dr. Colenbrander was the Director of the Department of Ophthalmology at California Pacific Medical Center where he directed the Low Vision Service from 1974 until his clinical retirement in 1998.
Congratulations Gus from all of us at Precision Vision!
Mary Anne C. Murphy, O.D.
Leverage a colleague’s technology or specialty care, or become the referred O.D. yourself.
Joseph Burns
Follow these 10 steps to avoid the looming cash crunch.
ICD-10, the new system for diagnostic codes, is coming October 1, 2014, and coding experts warn that practices caught unaware may suffer cash-flow shortages.
Noted Ophthalmologist, Dr. Donald Fletcher with special commentary by Dr. Gianfrancesco Villani discuss the development of and the uses for the SK Read Vision Test. Dr. Fletcher developed this test after his use of Drs Gordon Legge and J. Stephen Mansfield’s MNRead Test. The SK Read Test has applications for Low Vision Rehabilitation Practitioners (Ophthalmologists, Optometrists, and Occupational Therapists) as well as Clinical Practitioners.
Researchers at the University of North Carolina School of Medicine recently published new findings in the hunt for better treatment for macular degeneration. In studies using mice, a class of drugs known as MDM2 inhibitors proved highly effective at regressing the abnormal blood vessels responsible for vision loss associated with the decrease.
Glaucoma is one of the most common eye diseases affecting people over 40, and it can lead to debilitating vision impairment and even total vision loss if left untreated. Dr. Hylton R. Mayer, a board-certified Washington, DC Ophthalmologist, recently performed the iStent® Trabecular Micro-Bypass Stent procedure in the DC Metro to treat glaucoma in cataract surgery patients.